ArticleAngewandte Chemie (International ed. in English)2026
Highly Stereoselective Addition of β-Borylenamides to Aldehydes Enabled by Late‑Stage Ligand Modification.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The stereoselective synthesis of allylic alcohols bearing both a hydroxyl stereocenter and defined olefin geometry remains a significant challenge. While traditional methods predominantly furnish thermodynamically favored (E)-isomers, efficient access to enantiomerically enriched (Z)-configured counterparts is severely underdeveloped. Herein, we report an asymmetric addition of β-borylenamides to aldehydes by rhodium catalysis, enabling the synthesis of (Z)-hydroxy enamides with excellent stereocontrol. The requisite β-borylenamides are stereoconvergently prepared from mixed-olefin starting materials through directed electrophilic C-H borylation. A key innovation lies in the development of late‑stage modified ligands, readily accessible via direct arylation of phosphoramidites. This modular strategy circumvents traditional de novo ligand synthesis, thereby significantly accelerating the discovery and optimization of privileged ligands. The resulting allylic alcohol products undergo smooth reduction to furnish γ-amino alcohols with exceptional enantio- and diastereocontrol. The influence of the modified ligands on enantioselectivity was elucidated through density functional theory (DFT) calculations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.